|
CN101098854B
(zh)
|
2004-07-23 |
2012-12-05 |
恩多塞特公司 |
二价连接体及其轭合物
|
|
NZ599239A
(en)
|
2007-03-14 |
2013-10-25 |
Endocyte Inc |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
US9138484B2
(en)
|
2007-06-25 |
2015-09-22 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
WO2013126797A1
(en)
|
2012-02-24 |
2013-08-29 |
Purdue Research Foundation |
Cholecystokinin b receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
US20140079636A1
(en)
|
2012-04-16 |
2014-03-20 |
Dinesh U. Chimmanamada |
Targeted therapeutics
|
|
WO2013173391A1
(en)
|
2012-05-15 |
2013-11-21 |
Concortis Biosystems, Corp |
Drug-conjugates, conjugation methods, and uses thereof
|
|
US9662402B2
(en)
|
2012-10-16 |
2017-05-30 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
MX379355B
(es)
|
2012-12-21 |
2025-03-11 |
Altrubio Inc |
Enlazadores autodestructivos hidrofilos y conjugados de los mismos.
|
|
AU2014228489B2
(en)
|
2013-03-15 |
2018-11-15 |
Zymeworks Bc Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
WO2014197991A1
(en)
|
2013-06-12 |
2014-12-18 |
Muhammad Yousaf |
Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof
|
|
CA2923829A1
(en)
|
2013-09-10 |
2015-03-19 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
CN106132431A
(zh)
|
2013-10-15 |
2016-11-16 |
索伦托治疗有限公司 |
具有靶向分子和两种不同药物的药物偶联物
|
|
AU2014337555C1
(en)
|
2013-10-15 |
2021-01-28 |
Seagen Inc. |
PEGylated drug-linkers for improved Ligand-Drug Conjugate pharmacokinetics
|
|
WO2015066053A2
(en)
|
2013-10-28 |
2015-05-07 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
BR112016015105A8
(pt)
*
|
2013-12-27 |
2018-04-24 |
Var2 Pharmaceuticals Aps |
conjugados var2csa-droga
|
|
KR102384740B1
(ko)
*
|
2013-12-27 |
2022-04-07 |
자임워크스 인코포레이티드 |
약물 접합체를 위한 설폰아마이드-함유 연결 시스템
|
|
JP6664329B2
(ja)
*
|
2014-01-28 |
2020-03-13 |
トゥーベ・ファルマシューティカルズ・ゲー・エム・ベー・ハー |
コンジュゲーションのための新規な細胞毒性チューブリシン化合物
|
|
WO2015116774A1
(en)
|
2014-01-29 |
2015-08-06 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
GB201402006D0
(en)
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
JP6576942B6
(ja)
|
2014-03-03 |
2019-11-27 |
マドリガル ファーマシューティカルズ インコーポレイテッド |
標的治療薬
|
|
WO2015143004A1
(en)
|
2014-03-18 |
2015-09-24 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
KR102413079B1
(ko)
|
2014-05-28 |
2022-06-24 |
어젠시스 인코포레이티드 |
돌라프로인-돌라이소류인 펩타이드의 유도체
|
|
SG11201610620UA
(en)
|
2014-06-20 |
2017-01-27 |
Bioalliance Cv |
Anti-folate receptor aplha (fra) antibody-drug conjugates and methods of using thereof
|
|
ME03665B
(me)
|
2014-07-11 |
2020-10-20 |
Genmab As |
Antitela koja vezuju axl
|
|
EP3900742B1
(en)
*
|
2014-09-11 |
2024-05-15 |
Seagen Inc. |
Targeted delivery of tertiary amine-containing drug substances
|
|
RS62860B1
(sr)
|
2014-09-17 |
2022-02-28 |
Zymeworks Inc |
Citotoksična i antimitotička jedinjenja, i postupci upotrebe istih
|
|
JP2017534612A
(ja)
|
2014-10-14 |
2017-11-24 |
ポリセリックス・リミテッド |
Ｐｅｇの部分を含めた脱離基を含む試薬を用いるペプチド又はタンパク質のコンジュゲーションのための方法
|
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
|
WO2016094455A1
(en)
*
|
2014-12-08 |
2016-06-16 |
Sorrento Therapeutics, Inc. |
C-met antibody drug conjugate
|
|
US9968683B2
(en)
|
2014-12-17 |
2018-05-15 |
Organolinx Corp. |
Method for conjugating molecules
|
|
EP3250238B1
(en)
*
|
2015-01-28 |
2022-06-01 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
CN107635405A
(zh)
*
|
2015-02-06 |
2018-01-26 |
索伦托医疗有限公司 |
抗体药物缀合物
|
|
KR20170117473A
(ko)
*
|
2015-02-15 |
2017-10-23 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
리간드-세포독성 약물 접합체, 이의 제조 방법 및 이의 적용
|
|
CN106279352B
(zh)
*
|
2015-05-29 |
2020-05-22 |
上海新理念生物医药科技有限公司 |
海兔毒素10的衍生物及其应用
|
|
EP3308801A4
(en)
|
2015-06-09 |
2019-02-27 |
XDCExplorer (Shanghai) Co., Ltd. |
ANTIBODY-ACTIVE CONJUGATE, INTERMEDIATE PRODUCT, METHOD OF MANUFACTURE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
|
|
ME03772B
(me)
|
2015-07-10 |
2021-04-20 |
Genmab As |
Konjugati antitijela specifičnog za axl i lijeka za liječenje kancera
|
|
JP6759326B2
(ja)
|
2015-07-12 |
2020-09-23 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
細胞結合分子の共役のための架橋連結体
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
WO2017054080A1
(en)
*
|
2015-09-29 |
2017-04-06 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
WO2017058808A1
(en)
*
|
2015-10-02 |
2017-04-06 |
Sirenas Llc |
Anti-cancer compounds and conjugates thereof
|
|
EP3165237B1
(en)
|
2015-11-03 |
2018-12-19 |
Industrial Technology Research Institute |
Antibody-drug conjugate (adc) and method for forming the same
|
|
CN106729743B
(zh)
*
|
2015-11-23 |
2021-09-21 |
四川科伦博泰生物医药股份有限公司 |
抗ErbB2抗体-药物偶联物及其组合物、制备方法和应用
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
US11229708B2
(en)
|
2015-12-04 |
2022-01-25 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
AU2017206074B2
(en)
|
2016-01-08 |
2023-09-07 |
Altrubio Inc. |
Tetravalent anti-PSGL-1 antibodies and uses thereof
|
|
CN107029244B
(zh)
*
|
2016-02-04 |
2021-04-27 |
浙江昭华生物医药有限公司 |
抗her2抗体-药物偶联物及其应用
|
|
PE20181953A1
(es)
|
2016-03-02 |
2018-12-17 |
Eisai Randd Man Co Ltd |
Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso
|
|
KR102626498B1
(ko)
|
2016-03-25 |
2024-01-19 |
씨젠 인크. |
페길화된 약물-링커 및 그의 중간체의 제조를 위한 공정
|
|
WO2017172907A1
(en)
*
|
2016-03-29 |
2017-10-05 |
Sorrento Therapeutics, Inc. |
Calicheamicin antibody drug conjugates linking an amidoacetyl group to a sugar moiety on calicheamicin
|
|
HUE062120T2
(hu)
*
|
2016-03-29 |
2023-09-28 |
Toray Industries |
Peptid-származék és alkalmazása
|
|
MA45328A
(fr)
|
2016-04-01 |
2019-02-06 |
Avidity Biosciences Llc |
Compositions acide nucléique-polypeptide et utilisations de celles-ci
|
|
WO2017210288A1
(en)
*
|
2016-05-31 |
2017-12-07 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates having derivatives of amatoxin as the drug
|
|
CN109661400A
(zh)
|
2016-06-17 |
2019-04-19 |
美真达治疗公司 |
用于耗尽cd117+细胞的组合物和方法
|
|
CN108697809A
(zh)
*
|
2016-08-23 |
2018-10-23 |
四川科伦博泰生物医药股份有限公司 |
一种抗体-药物偶联物及其制备方法和应用
|
|
US10517958B2
(en)
|
2016-10-04 |
2019-12-31 |
Zymeworks Inc. |
Compositions and methods for the treatment of platinum-drug resistant cancer
|
|
KR102562760B1
(ko)
*
|
2016-11-25 |
2023-08-04 |
맵웰 (상하이) 바이오사이언스 컴퍼니, 리미티드 |
항체-약물 접합을 위한 이-치환된 말레익 아미드 링커 및 이의 제조 방법 및 용도
|
|
CN108101825B
(zh)
*
|
2016-11-25 |
2022-02-22 |
迈威(上海)生物科技股份有限公司 |
用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
CN109810039B
(zh)
*
|
2017-11-22 |
2021-11-12 |
迈威(上海)生物科技股份有限公司 |
一种用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
US10864279B2
(en)
|
2016-12-16 |
2020-12-15 |
Industrial Technology Research Institute |
Linker-drug and antibody-drug conjugate (ADC) employing the same
|
|
MX2019008199A
(es)
|
2017-01-06 |
2019-11-25 |
Avidity Biosciences Llc |
Composiciones de acido nucleico polipeptido y metodos de induccion de la omision de exon.
|
|
CN110461876B
(zh)
|
2017-01-20 |
2024-05-17 |
海德堡医药研究有限责任公司 |
用于耗尽cd137+细胞的组合物和方法
|
|
WO2018175994A1
(en)
|
2017-03-24 |
2018-09-27 |
Seattle Genetics, Inc. |
Process for the preparation of glucuronide drug-linkers and intermediates thereof
|
|
BR112019020049A2
(pt)
*
|
2017-04-06 |
2020-05-12 |
Hangzhou Dac Biotech Co., Ltd |
Composto conjungado, célula tumoral, composição farmacêutica, e, agentes sinérgicos.
|
|
US11207420B2
(en)
|
2017-04-19 |
2021-12-28 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Cytotoxin and conjugate, uses of same and preparation method therefor
|
|
US11491145B2
(en)
|
2017-06-20 |
2022-11-08 |
Madrigal Pharmaceuticals, Inc. |
Combination therapies comprising targeted therapeutics
|
|
CA3067572A1
(en)
|
2017-06-20 |
2018-12-27 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
WO2018235024A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
GB201711809D0
(en)
|
2017-07-21 |
2017-09-06 |
Governors Of The Univ Of Alberta |
Antisense oligonucleotide
|
|
WO2019023247A1
(en)
|
2017-07-25 |
2019-01-31 |
Immutics, Inc. |
TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
|
|
US10799598B2
(en)
|
2017-08-01 |
2020-10-13 |
Sorrento Therapeutics, Inc. |
Disulfide bridging conjugates
|
|
CN111051329B
(zh)
|
2017-08-10 |
2024-07-30 |
住友制药株式会社 |
哈米特林衍生物及它们的抗体药物复合物
|
|
BR112020004495A2
(pt)
|
2017-09-08 |
2020-09-08 |
Seattle Genetics, Inc. |
composto, composição, e, método para preparar uma composição.
|
|
WO2019071028A1
(en)
|
2017-10-04 |
2019-04-11 |
Avidity Biosciences Llc |
NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
|
|
US11612666B2
(en)
*
|
2017-11-30 |
2023-03-28 |
Seagen Inc. |
Process for the preparation of drug linker compounds
|
|
WO2019113393A1
(en)
|
2017-12-06 |
2019-06-13 |
Avidity Biosciences Llc |
Compositions and methods of treating muscle atrophy and myotonic dystrophy
|
|
CA3080236A1
(en)
|
2017-12-15 |
2019-06-20 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Bioactive molecule conjugate, preparation method and use thereof
|
|
CN111447939B
(zh)
*
|
2018-01-30 |
2024-07-12 |
四川科伦博泰生物医药股份有限公司 |
制备偶联物的方法
|
|
AU2019225845B2
(en)
*
|
2018-02-20 |
2024-06-20 |
Seagen Inc. |
Hydrophobic Auristatin F compounds and conjugates thereof
|
|
US12172986B2
(en)
|
2018-06-01 |
2024-12-24 |
Eisai R&D Management Co., Ltd |
Splicing modulator antibody-drug conjugates and methods of use
|
|
US11998544B2
(en)
|
2018-06-01 |
2024-06-04 |
Eisai R&D Management Co., Ltd. |
Methods of using splicing modulators
|
|
US20210276971A1
(en)
|
2018-06-20 |
2021-09-09 |
The Research Foundation For The State University Of New York |
Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
|
|
AU2018445278B2
(en)
*
|
2018-10-12 |
2022-07-28 |
Hangzhou Dac Biotech Co., Ltd |
Conjugation linkers containing 2,3-diaminosuccinyl group
|
|
WO2020081493A1
(en)
|
2018-10-16 |
2020-04-23 |
Molecular Templates, Inc. |
Pd-l1 binding proteins
|
|
CA3114931A1
(en)
|
2018-12-13 |
2020-06-18 |
Eisai R&D Management Co., Ltd. |
Herboxidiene antibody-drug conjugates and methods of use
|
|
EP3897734A4
(en)
*
|
2018-12-21 |
2022-12-07 |
Seagen Inc. |
ADC COMPRISING MULTIPLEX THIOL LINKERS
|
|
IL319265A
(en)
|
2018-12-21 |
2025-04-01 |
Avidity Biosciences Inc |
Anti-transferrin receptor antibodies and their uses
|
|
EP3918323A4
(en)
|
2019-01-30 |
2022-12-28 |
TrueBinding, Inc. |
ANTI-GAL3 ANTIBODIES AND USES THEREOF
|
|
JP7479302B2
(ja)
|
2019-02-13 |
2024-05-08 |
住友ファーマ株式会社 |
ヘミアスタリン誘導体とその抗体薬物複合体
|
|
EP3925668A4
(en)
|
2019-02-13 |
2022-11-09 |
Sumitomo Pharma Co., Ltd. |
HEMIASTERLINE DERIVATIVE WITH CYSTEINE RESIDUES
|
|
CN109824759A
(zh)
*
|
2019-03-08 |
2019-05-31 |
联宁（苏州）生物制药有限公司 |
一种用于抗体药物偶联物的药物-连接子mc-mmaf的制备方法及其中间体
|
|
AU2020263487A1
(en)
|
2019-04-25 |
2021-12-16 |
Avidity Biosciences, Inc. |
Nucleic acid compositions and methods of multi-exon skipping
|
|
JP7581252B2
(ja)
|
2019-06-06 |
2024-11-12 |
アビディティー バイオサイエンシーズ，インク． |
Ｕｎａアミダイトおよびその使用
|
|
US11578090B2
(en)
|
2019-06-06 |
2023-02-14 |
Avidity Biosciences, Inc. |
Nucleic acid-polypeptide compositions and uses thereof
|
|
WO2021055816A1
(en)
|
2019-09-18 |
2021-03-25 |
Molecular Templates, Inc. |
Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds
|
|
CN115768483A
(zh)
|
2020-01-13 |
2023-03-07 |
西纳福克斯股份有限公司 |
抗体与免疫细胞衔接器的缀合物
|
|
JP2023511857A
(ja)
|
2020-01-13 |
2023-03-23 |
シンアフィックス ビー．ブイ． |
付加環化を介して両側官能化された抗体
|
|
WO2021144314A1
(en)
|
2020-01-13 |
2021-07-22 |
Synaffix B.V. |
Via cycloaddition bilaterally functionalized antibodies
|
|
EP4110817A1
(en)
|
2020-02-26 |
2023-01-04 |
Sorrento Therapeutics, Inc. |
Activatable antigen binding proteins with universal masking moieties
|
|
BR112022018002A2
(pt)
*
|
2020-03-09 |
2022-11-08 |
Sigma Aldrich Co Llc |
Preparação eficiente de análogos de dolastatina e auristatina por meio de um intermediário comum
|
|
TW202144572A
(zh)
|
2020-03-19 |
2021-12-01 |
美商亞維代堤生物科學公司 |
治療臉肩胛肱骨肌肉失養症之組合物及方法
|
|
WO2021195469A1
(en)
|
2020-03-27 |
2021-09-30 |
Avidity Biosciences, Inc. |
Compositions and methods of treating muscle dystrophy
|
|
US10987487B1
(en)
|
2020-04-29 |
2021-04-27 |
Cure Medical Llc |
Gripper sleeve for urinary catheter
|
|
WO2021242776A2
(en)
|
2020-05-26 |
2021-12-02 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking galectin-3
|
|
BR112022024833A2
(pt)
|
2020-06-05 |
2023-02-14 |
Eisai R&D Man Co Ltd |
Conjugados anticorpo anti-bcma-fármaco e métodos de uso
|
|
EP4172141A1
(en)
|
2020-06-26 |
2023-05-03 |
Synaffix B.V. |
Methods for the preparation of linker payload constructs
|
|
NL2026400B1
(en)
|
2020-09-02 |
2022-05-04 |
Synaffix Bv |
Methods for the preparation of bioconjugates
|
|
EP4208259A2
(en)
|
2020-09-04 |
2023-07-12 |
NovaRock Biotherapeutics, Ltd. |
Nectin-4 antibodies and uses thereof
|
|
WO2022058395A1
(en)
|
2020-09-15 |
2022-03-24 |
Synaffix B.V. |
Antibody-exatecan conjugates
|
|
NL2026947B1
(en)
|
2020-11-20 |
2022-07-01 |
Synaffix Bv |
Tyrosine-based antibody conjugates
|
|
UY39587A
(es)
|
2020-12-23 |
2022-07-29 |
Univ Muenchen Ludwig Maximilians |
Conjugados anticuerpo-droga mejorados dirigidos contra cd30 y usos de los mismos
|
|
US20230390411A1
(en)
*
|
2021-01-28 |
2023-12-07 |
Nanjing Chempion Biotechnology Co., Ltd. |
Conjugate and use thereof
|
|
US20250262314A1
(en)
|
2021-02-08 |
2025-08-21 |
Synaffix B.V. |
Multifunctional antibodies
|
|
EP4301418A1
(en)
|
2021-03-03 |
2024-01-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates comprising an anti-bcma antibody
|
|
CA3213295A1
(en)
|
2021-03-17 |
2022-09-22 |
Molecular Templates, Inc. |
Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens
|
|
CN116897149A
(zh)
*
|
2021-03-30 |
2023-10-17 |
上海复旦张江生物医药股份有限公司 |
一种连接基药物偶联物的制备方法及其中间体
|
|
JP2024526764A
(ja)
|
2021-07-13 |
2024-07-19 |
トゥルーバインディング，インコーポレイテッド |
タンパク質凝集を防止する方法
|
|
CN118265544A
(zh)
|
2021-09-16 |
2024-06-28 |
艾维迪提生物科学公司 |
治疗面肩肱型肌营养不良的组合物和方法
|
|
WO2023086768A1
(en)
|
2021-11-09 |
2023-05-19 |
Truebinding, Inc. |
Methods of treating or inhibiting cardiovascular diseases
|
|
WO2023122347A2
(en)
|
2021-12-23 |
2023-06-29 |
Mirecule, Inc. |
Compositions for delivery of polynucleotides
|
|
WO2023173026A1
(en)
|
2022-03-10 |
2023-09-14 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
US12071621B2
(en)
|
2022-04-05 |
2024-08-27 |
Avidity Biosciences, Inc. |
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
|
|
KR20250054842A
(ko)
|
2022-07-29 |
2025-04-23 |
리제너론 파마슈티칼스 인코포레이티드 |
뇌 및 근육으로의 트랜스페린 수용체(tfr)-매개 전달을 위한 조성물 및 방법
|
|
JP2025526869A
(ja)
|
2022-08-15 |
2025-08-15 |
シンアフィックス ビー．ブイ． |
アントラサイクリン及びそのコンジュゲート
|
|
AU2023350248A1
(en)
|
2022-09-30 |
2025-04-17 |
Shanghai De Novo Pharmatech Co., Ltd. |
Benzazepine derivative, conjugate containing same, and use thereof
|
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
|
EP4389152A1
(en)
|
2022-12-23 |
2024-06-26 |
Synaffix B.V. |
Conjugates of pbd prodrugs
|
|
CN116621927B
(zh)
*
|
2023-01-09 |
2024-03-26 |
联宁（苏州）生物制药有限公司 |
带有伊喜替康和C-lock定点偶联基团的抗体偶联中间体、偶联方法及抗体偶联药物
|
|
EP4410313A1
(en)
|
2023-01-31 |
2024-08-07 |
Synaffix B.V. |
Homogeneous antibody-conjugates with high payload loading
|
|
AU2024229817A1
(en)
|
2023-02-28 |
2025-08-14 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Chemical coupling linker and use thereof
|
|
WO2024211236A2
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211234A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211235A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024218164A1
(en)
|
2023-04-17 |
2024-10-24 |
Synaffix B.V. |
Stable 4-isoxazoline conjugates
|
|
EP4450093A1
(en)
|
2023-04-17 |
2024-10-23 |
Synaffix B.V. |
Cleavable immune cell engagers
|
|
US12491257B2
(en)
|
2023-06-27 |
2025-12-09 |
Avidity Biosciences, Inc. |
Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conjugates
|
|
US12409230B2
(en)
|
2023-06-30 |
2025-09-09 |
Avidity Biosciences, Inc. |
Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
WO2025126157A1
(en)
|
2023-12-15 |
2025-06-19 |
Advesya |
Anti-il-1rap binding domains and antibody-drug conjugates thereof
|
|
CN117964682A
(zh)
*
|
2024-01-12 |
2024-05-03 |
杭州爱科瑞思生物医药有限公司 |
Dolastatin衍生物及其制备方法和应用
|
|
WO2025238253A1
(en)
|
2024-05-16 |
2025-11-20 |
Synaffix B.V. |
Antibody-oligonucleotide conjugates
|